Depression in RA Patients May Be Higher Than Previously Reported
People with severe rheumatoid arthritis (RA) can be depressed about their health situation and anxious about what lies ahead. A new study looked at just how many people with RA were depressed.
FDA Approves Two Meds for New Use
New options developed this week for patients coping with two very different arthritic conditions. T he US Food and Drug Administration (FDA) has approved two medications for treatment of both rheumatoid arthritis and ankylosing spondylitis.
New Drug for Crohn's Patients
Maybe this is the end of long-term stomach aches and pains, at least for patients with Crohn's disease who don't respond to the common treatment.
Treating Crohn's Disease
Crohn's disease is a condition that can cause swelling and irritation in any part of the digestive tract, from the mouth all the way to the rectum. While there is no cure for Crohn's disease, there are ways to control the swelling and other symptoms.
No Doubt About Arthritis Drug's Benefit
A few years ago, the FDA warned that certain drugs may raise the risk of cancer in children with juvenile arthritis. While it still seems these children are more prone to cancer, the drugs might not be to blame.
The RA Heart Left Unprotected
The inflammation of rheumatoid arthritis can affect more than the joints; it also poses a threat to the heart. When it comes to protecting the heart health of rheumatoid arthritis patients, certain drugs are falling short.
FDA Focus on TNF Blockers
A class of drugs is now under suspicion of causing cancer in children, adolescents and young adults under the age of 30. These are called Tumor Necrosis Factor (TNF) blockers, and the U.S. Food and Drug Administration (FDA) recently released an update regarding its ongoing safety review of these drugs.
Advancing Crohn's Disease Treatment
Even 15 or 20 years ago hearing a diagnosis of Crohn's disease was bad news. Advances in treatment now mean that the disease is manageable and patients can live a normal life. It's no longer the death sentence it once was.
The Low Down on Down Low Testosterone
By the age of 35, men's testosterone levels begin to drop by one or two percent each year. By the age of 50, 30% of men are already below the normal testosterone range and that number increases as years advance.